Literature DB >> 11092028

The biology of melanoma micrometastases.

R L Barnhill1.   

Abstract

The biology and significance of micrometastases remain poorly understood. Whether such deposits represent hypothetical "dormant" metastases, simply the earliest metastases recognizable, or both has not been resolved. Attempting to answer the latter question among many others, we carried out studies on the rates of proliferation, and microvessel counts in melanoma micrometastases taken from sentinel lymph nodes as compared to conventional melanoma lymph node macrometastases. We found that these micrometastases were not vascularized and had low (and comparable) rates of both proliferation and apoptosis, suggesting a steady or dormant state. On the other hand, the macrometastases were fully vascularized and more proliferative, i.e., they had rates of proliferation that were significantly higher compared to the micrometastases and rate of apoptosis. How micrometastases develop is also poorly understood. Tumor cells are thought to arrive in lymph nodes and other sites through the blood and lymphatic circulation and to extravasate. However, in addition to the latter explanation, another mechanism may be operable which we have proposed as extravascular migratory metastasis. In studies of metastatic melanoma we have identified melanoma cells positioned on the surface of endothelial cells both by light and electron microscopy. We have also identified ultrastructurally the presence of an amorphous matrix interposed between the latter two cell types that shows immunostaining for laminin and, recently, the beta-2 chain of laminin. Thus, we currently believe that the latter form of "free" laminin may play a role in this proposed mechanism of metastasis and thus in the formation of micrometastases.

Entities:  

Mesh:

Year:  2001        PMID: 11092028

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  8 in total

1.  Breast carcinoma and malignant melanoma metastasis within a single axillary lymph node.

Authors:  Kirstin A Carswell; Kasim A Behranwala; Ashutosh Nerurkar A; Gerald P H Gui
Journal:  Int Semin Surg Oncol       Date:  2006-10-06

2.  Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice.

Authors:  L Hou; Y Li; Y H Jia; B Wang; Y Xin; M Y Ling; S Lü
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Diminished metastasis in tetraspanin CD151-knockout mice.

Authors:  Yoshito Takeda; Qinglin Li; Alexander R Kazarov; Mathieu Epardaud; Kutlu Elpek; Shannon J Turley; Martin E Hemler
Journal:  Blood       Date:  2011-05-02       Impact factor: 22.113

4.  Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Authors:  Andrea P Moy; Lyn M Duncan; Stefan Kraft
Journal:  Lab Invest       Date:  2016-12-19       Impact factor: 5.662

5.  Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model.

Authors:  De-sheng Wu; Cong-mei Wu; Tian-hua Huang; Qin-dong Xie
Journal:  Radiat Environ Biophys       Date:  2007-11-30       Impact factor: 1.925

6.  Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.

Authors:  V Davids; S H Kidson; G S Hanekom
Journal:  Mol Pathol       Date:  2003-02

7.  Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis.

Authors:  Claire Lugassy; Hynda K Kleinman; Jean A Engbring; Danny R Welch; John F Harms; Robyn Rufner; Ghanem Ghanem; Steven R Patierno; Raymond L Barnhill
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

8.  Angiotropic metastatic malignant melanoma in a canine mammary gland.

Authors:  Hai Jie Yang; Eun-Mi Lee; Ah-Young Kim; Eun-Joo Lee; Il-Hwa Hong; Sung-Oh Huh; Kyu-Shik Jeong
Journal:  Lab Anim Res       Date:  2011-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.